Pregnancy and Neonatal Outcomes following Prenatal Exposure to Cabotegravir Long Acting (CAB LA): Data from the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) (215163)

16/02/2022
05/09/2025
EU PAS number:
EUPAS45777
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

viiv-215163-protocol-orig-redact.pdf

English (1.03 MB - PDF) View document
Study results
Study report
Other information